Chemotherapeutical effects on Wnt16 secretion in human gliomas

descriptionPublicationkeyboard_double_arrow_right Conference object 01 Jan 2014Embargo end date: 13 May 2014 English Publisher:German Medical Science GMS Publishing House; Düsseldorf

Authors: Dreher, L; Goldbrunner, R; Timmer, M;

doi: 10.3205/14dgnc424

Chemotherapeutical effects on Wnt16 secretion in human gliomas

- Summary
- Subjects
- Metrics

Abstract

Objective: Acquired chemotherapy resistance is a persistent problem in treatment of cancer. Recently, Wnt16 came up as a relevant protein in development of cancer chemoresistance. It was found to be overexpressed in peritumoral tissue after chemotherapy in several non-CNS cancers like e.g. prostate [for full text, please go to the a.m. URL]

65. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC)

Keywords

Wnt16, ddc: 610, glioma, chemoresistance, 610 Medical sciences; Medicine

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	0
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average